Supply Chain Latest News news and information

As the number and array of health apps for mobile devices continue to explode, the federal government will keep its regulatory focus on a narrow band of products that pose the most potential risk.
FULL STORY »

Prices paid in the U.S. for medical devices, including those that regulate the heart's rhythm and replacements for hips and knees, have plunged as much as one-third since 2007 as hospitals clamped down on spending.
FULL STORY »

HHS is searching for the best idea for a system that captures essential data from durable medical equipment, such as loss of power, GPS location and privacy-protected user information during emergencies.
FULL STORY »

A new rule requiring medical devices to be marked with identification information is expected to improve patient safety and make hospital supply operations more efficient. But the Food and Drug Administration will take another seven years to roll out the system, and much of its success depends on...
FULL STORY »

Novartis says it is investigating claims that its eye-care unit, Alcon, bribed doctors in over 200 hospitals in China to promote its lens implants.
FULL STORY »

A trade group representing the orthotics and prosthetics industry is accusing the CMS of failing to enforce anti-fraud and abuse laws against unlicensed providers at a time when legitimate providers are coming under fire from increasingly aggressive Medicare recovery auditors.
FULL STORY »

U.S. health regulators have placed a ban on imported drugs from a factory operated by India's largest pharmaceutical company, Ranbaxy Laboratories, due to manufacturing and quality control problems.
FULL STORY »

Chinese authorities visited a local office of German drugmaker Bayer in late August to investigate a potential case of unfair competition, the company said on Friday.
FULL STORY »

Johnson & Johnson recalled another product Wednesday, pulling some vials of its antipsychotic treatment Risperdal Consta after discovering mold during routine quality testing.
FULL STORY »

The Food and Drug Administration is requiring stronger warning labels on prescription painkillers like OxyContin, in the government's latest attempt to reduce overdose deaths caused by the long-acting medications.
FULL STORY »